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Abstract 
Objective: The objective of this selective EBM review is to determine whether or not “Is 
acupuncture (including electroacupuncture) beneficial on the quality of life in patients with 
Parkinson’s disease?” 
Study design: Systematic review of three primary studies published in 2015 and 2016 
Data sources: Two randomized control trials and one non-randomized control trial were chosen 
through PubMed to study the effects of acupuncture (including electroacupuncture) improving 
the quality of life and activities of daily living in patients with Parkinson’s disease 
Outcome(s) measured: The outcomes were measured by using two types of questionnaires: A 
39-item Parkinson Disease Questionnaire (PDQ-39) to measure quality of life or Unified 
Parkinson Disease Rating Scale II (UPDRS) to measure activities of daily living  
Results: Chen et al. (2015) found that the UPDRS II score increased by 65% in the acupuncture 
treatment group compared to 15% increase in the control group (p=0.003). Kluger et al. (2016) 
found that the PDQ-39 score decreased for the acupuncture treatment group (27.4+10.0 to 
21.6+12.2, p=0.0002) as did the score for the control group (31.2+14.9 to 24.5+15.0, 
p=<0.0001); when the score decreases were compared between the acupuncture group and 
control group, there was no significant difference (p=0.6067). Toosizadeh et al. (2015) found a 
46% decrease in the UPDRS II in the electroacupuncture group when compared to baseline 
(p=<0.0001), but a 9% increase in the UPDRSII score in the control group (p=0.8).  
Conclusions: There is conflicting evidence as to the efficacy of acupuncture and 
electroacupuncture in the treatment of quality of life in patients with Parkinson’s disease. Chen 
et al. (2015) and Toosizadeh et al. (2015) both showed acupuncture and electroacupuncture 
provide an improvement in quality of life. Kluger at al. (2016) did not find acupuncture to be 
more effective compared to sham acupuncture; however, acupuncture and sham treatments both 
had a significant effect in improving quality of life.  
Key words: Parkinson disease, acupuncture 
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Introduction 
Parkinson’s disease (PD) is a neurocognitive disease that causes progressively worsening 
motor symptoms. Its characteristic symptoms are tremors, bradykinesia, rigidity and instability 
of posture.1 As these symptoms progress, patients have increasing difficulty with day to day 
activities such as getting dressed, bathing, walking which then leads to a decreased quality of 
life. To continually help these patients, new treatment methods are being studied.  
Developing new and more efficacious treatments for Parkinson’s disease is beneficial 
because it will improve the lives of patients, alleviate costs and decrease adverse outcomes. 
Parkinson’s disease affects about one million people in America and about five million people 
worldwide.1 It is the second most common neurocognitive disorder in the world.2 Every year, 
$25 billion are spent on treatment, social security payments and lost income due to an inability to 
work.3 Treatment for a single patient costs $2,500 for medications and $100,000 for therapeutic 
surgery every year.3 A person with Parkinson’s disease is 1.44 times more likely to be admitted 
to the hospital than another person who is in the same age and sex category.4 Those admitted 
with Parkinson’s disease also have a greater morbidity and mortality rate.4 
Parkinson’s disease is diagnosed by the four characteristic motor symptoms mentioned 
before along with many other motor and non-motor symptoms, such as freezing, speech 
difficulty, sleep difficulty, depression, anxiety, cognitive issues.1 The hallmark characteristic of 
the disease is the degeneration of dopamine neurons.1 There is still much that needs to be learned 
though. The exact cause is still unknown but it is believed to be a combination of genetic and 
environmental factors.1  
Current treatments for Parkinson’s disease are targeted at relieving motor symptoms. One 
of the most important prescription medications used is carbidopa/levodopa.1 Of all other 
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treatments, this is the most effective at symptomatic relief. However, over time, the duration of 
effectiveness of the drug begins to decrease, which is called the “wearing off effect”.1 As 
patients progress in their disease and lose benefit from the drug, they may cycle between being 
“on” and “off”, the former being symptom relief and the latter characterized by severe motor 
symptoms and painful dystonic episodes.1 Other classes of prescription medications used are 
dopamine agonists, anticholinergics, MAO-B inhibitors and COMT inhibitors.1 Some of these 
are used as monotherapy or as adjunct treatments with carbidopa/levodopa. In addition to 
prescription medications, there are two surgical treatments. Deep brain stimulation involves 
implanting electrodes to stimulate the brain and Duodopa involves delivering 
carbidopa/levodopa intraintestinally as a gel formulation.1 
Despite the current treatments available, there are still motor and other non-motor 
symptoms that are not addressed. However, these affect the quality of life and activities of daily 
living in Parkinson’s disease patients. Acupuncture is a method that is not as invasive as surgical 
treatments and does not cause imbalance in chemical levels like other medications while 
attempting to improve other symptoms of Parkinson’s disease. This systematic review will 
evaluate two randomized controlled trials and one non-randomized controlled trial to assess the 
use of acupuncture (and electroacupuncture) in improving activities of daily living and quality of 
life in Parkinson’s disease patients. 
Objective 
The objective of this selective EBM review is to determine whether or not “Is acupuncture 
(including electroacupuncture) beneficial on the quality of life in patients with Parkinson’s 
disease?” 
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Methods 
 Among the three studies used in this review two were randomized controlled trials and 
one was a non-randomized controlled trial. All three included Parkinson’s disease patients 
greater than 40 years old. One study by Toosizadeh et al. also included patients without the 
diagnosis of Parkinson’s disease; the interventions used were acupuncture and 
electroacupuncture.5 Toosizadeh et al. and Kluger et al.  compared acupuncture or 
electroacupuncture, respectively, against a sham treatment.5,6 Chen et al. compared acupuncture 
used with western medicine against only western medicine.2 The three studies measured quality 
of life and activities of daily living.  
 Data sources were searched using the key words “acupuncture” and “Parkinson” in 
PubMed-NCBI. The studies were chosen if they addressed the research question and whether the 
outcomes studied were ones the patient would care about (POEMs). All articles were published 
data in the English language. Only primary research studies published after 2007 were included 
and studies with patients younger than 40 years old were excluded. The mean change from 
baseline, t test value, p-values, CI and NNT were used to determine clinical significance. 
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Table 1: Demographics & characteristics of included studies 
Study Type #pts Age 
(yrs) 
Inclusion 
criteria 
Exclusion 
criteria 
W/D Interventions 
Chen FP, 
Chang CM, 
Shiu JH, et 
al., 20152 
Non- 
random
ized 
controll
ed trial 
40 55 or 
older 
-Diagnosed 
with PD for 
over 6 
months with 
Core 
Assessment 
Program for 
Intracerebral 
Transplantati
on (CAPIT) 
 
-Severe 
diseases of 
heart, brain, 
liver, 
kidneys, 
endocrine or 
hematopoiet
ic system 
-Psychosis 
or dementia 
0 15 minutes 
of 
acupuncture 
therapy two 
times a week 
Kluger 
BM, 
Rakowski 
D, 
Christian 
M, et al., 
20166 
Rando
mized 
controll
ed trial  
94 40-
99 
-UK Brain 
Bank criteria 
for probable 
PD 
-fluent in 
English 
-self-
reported 
moderate or 
severe 
fatigue using 
the 
International 
Parkinson 
and 
Movement 
disorder 
society 
UPDRS 
fatigue item 
-dementia 
-presence of 
another 
medical 
condition 
expected to 
produce 
fatigue 
-active 
depression 
-presence of 
an untreated 
sleep 
disorder 
-exposure to 
acupuncture 
within the 
past 6 
months 
5 30 minutes 
of 
acupuncture 
therapy two 
times a week, 
at least one 
day apart, for 
6 weeks. It 
was followed 
by a 12-week 
wash out 
period 
 
Toosizadeh 
N, Lei H, 
Schwenk 
M, et al., 
20155 
Rando
mized 
controll
ed trial 
59 55 or 
older 
-55 years or 
older with 
idiopathic 
PD 
diagnosed by 
movement 
disorder 
specialists 
based on UK 
brain bank 
criteria 
 
- Diagnosed 
with any 
type of 
neurological 
disorder 
other than 
PD or if 
they have 
prior 
experience 
of EA 
therapy 
Not 
specified 
by 
authors 
30 minutes 
of 
electroacu-
puncture 
once a week 
for 3 weeks  
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Outcomes Measured  
Chen et al. used the Unified Parkinson Disease Rating Scale II (UPDRS II) to measure 
activities of daily living.2 Each patient took the survey before they received any acupuncture 
treatment, after 9 weeks of treatment and at 18 weeks of treatment.2 The score was compared 
between the groups receiving acupuncture treatment and western medicine with the group 
receiving only western medicine if there was an improvement in the score.2 
Toosizadeh et al. also used the UPDRS II to measure activities of daily living.5 The 
interview was conducted by a trained examiner. It was given to each patient before they received 
electroacupuncture treatment at an “off medication stage”, which was defined as greater than 12 
hours after the last medication dose they took, and after three weeks of electroacupuncture 
treatment.5 The trials were completed with both assessors and participants blinded.5 The score 
was compared between the groups receiving electroacupuncture treatment and sham treatment 
only if there was an improvement in the score.5 
Kluger et al. used the 39-item Parkinson Disease Questionnaire (PDQ39), a self-report 
survey, to measure quality of life.6 The survey was completed before any acupuncture treatment 
and 6 weeks after acupuncture treatment.6 Participants were blinded during treatments.  
Results 
The three studies used for this systematic review reviewed the efficacy in acupuncture, or 
electroacupuncture, in improving activities of daily living and quality of life in patients with 
Parkinson’s disease. The inclusion and exclusion criteria of the studies are outlined in Table 1.  
Chen et al. had 40 participants in their 18 week study.2 They were placed into either the 
acupuncture and western medicine treatment group (experimental group) or only western 
medicine treatment group (control group), with 20 participants in each group. At baseline, there 
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was found to be no significant difference in the UPDRS II score between the experimental and 
control groups (p=0.765).2 After 18 weeks, 65% of patients in the experimental had a score 
improvement compared to 15% of patients in the control group (p=0.003).2 There was a large 
treatment efficacy, represented by numbers needed to treat (NNT) (Table 2). Relative benefit 
increase and absolute benefit increase were also calculated into Table 2. When the mean change 
in score at 18 weeks was compared to baseline scores, within each group, there was no 
significant difference (significant difference was defined as p <0.05).2 There were no specific 
adverse events or side effects reported in this study.  
 
Table 2: Treatment efficacy analysis and statistical significance  
CER EER RBI ABI NNT p-value 
15% 65% 333% 50% 2 0.003 
 
  
Toosizadeh et al. had a total of 59 participants in their 3 week study.5 Fifteen participants 
had Parkinson’s disease and 44 participants were healthy adults. Patients were either placed into 
the group receiving electroacupuncture treatment (experimental group) or a sham treatment 
(control group); twice as many PD patients were placed into the experimental group than the 
control group.5 Baseline comparisons were also made between the experimental group and 
control group with no significant difference found between the two groups (p>0.11).5 There was 
a 46% decrease in the UPDRSII score from before treatment to after treatment in the 
experimental group (p<0.0001) but a 9% increase in the UPDRSII score from before treatment to 
after treatment in the control group (p=0.8).5 When the mean changes of the experimental and 
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control groups were compared with each other, there was a significant difference in the UPDRS 
II score (p=0.02) (Table 3).5 The difference between the mean changes was large, indicating a 
large treatment efficacy. The confidence interval is also reported in Table 3. There was no 
statement indicating adverse effects or side effects in this study.  
 
Table 3: mean change after treatment in UPDRS II score and statistical significance 
 
 
  
Kluger et al. had a total of 94 participants in their 6 week study.6 Participants were 
equally split between two groups: the first receiving acupuncture treatment (experimental) and 
the second receiving a sham treatment (control). After treatment, there was a significant 
difference between the PDQ39 score at baseline and 6 weeks in both the experimental and 
control groups (p=0.0002, p=<0.0001 respectively).6 When the changes were compared between 
the two groups, there was no significant difference (p=0.6067).6 There was a small mean change, 
indicating a small treatment efficacy (Table 4). One participant experienced increased 
constipation as an adverse event.6 There was a high treatment protocol compliance showing that 
99.5% of treatments were completed.6  
 
 
 
 
 
Mean change of experimental 
group from baseline + SD 
Mean change of control 
group from baseline + SD 
Mean change 
difference  
95% CI p-value 
7.2 + 5.5  0.4 + 3.4 6.8 + 2.1 (-5.9) to (-0.5) 0.02 
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Table 4: mean change after treatment in PDQ39 score and statistical significance  
Intervention Mean + SD 
at week 1 
Mean + SD 
at week 6 
Mean 
changes from 
baseline + SD 
Mean 
change 
difference + 
SD 
p-value 
Acupuncture  27.4 + 10.0 21.6 + 12.2 5.8 + 2.2 N/A 0.0002 
sham 31.2 + 14.9 24.5 + 15.0 6.7 + (- 0.1) N/A <0.0001 
Between 
acupuncture 
and sham  
N/A N/A N/A -0.9 + 2.3 0.6067 
 
Discussion 
Acupuncture is the use of needles, electric current or heat to stimulate meridian points, 
which are areas that were thought to correct energy flow of the body.7 Modern theories suggest 
that it may help by blocking neurotransmission or endorphin release or neurotransmitter 
stimulation.7 This practice has become more widely popular in America; it is regulated in 40 
states and the District of Columbia.7 It has been utilized for many different conditions and 
ailments. The most common areas where research has shown possible effectiveness is for back 
pain, chemotherapy-induced nausea and vomiting, fibromyalgia, insomnia, knee pain and 
migraines.7 As of this point, there is not enough evidence about the efficacy of acupuncture in 
PD.7  
There are some studies that have shown safe usage of acupuncture for as long as periods 
of 24 months, and also for use in children and pregnancy; Electroacupuncture has insufficient 
evidence for use in pregnancy and is not recommended.7 There are rarely side effects associated 
with acupuncture treatment. However, some minor side effects that are possible are nausea, 
vomiting, dizziness, pain and fainting.7 Some examples of rare cases of more serious injuries are 
serious infections, including HIV and hepatitis, organ puncture, particularly lung, hematomas 
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and broken and migrating needles.8 Most side effects of acupuncture are usually due to 
negligence or lack of training.8 Despite the rarity of these side effects, there are still certain 
conditions in which acupuncture is contraindicated, such as, arrhythmia, anemia and a number of 
other conditions.8 However, there also appears to be no set standard for contraindications to 
acupuncture.8 
A study by Nadin et al. showed that there was an increase in the amount of consumers 
who used acupuncture between the years 2002 and 2012.9 However, many did not have health 
insurance coverage for acupuncture.9 If they did, it was only partial coverage.9 Therefore, these 
data show that insurance coverage for acupuncture is not increasing even though consumer usage 
is. For those without the monetary means of paying out of pocket for acupuncture, this could be a 
barrier to trying this treatment.   
The limitations of the studies mentioned in this review that must also be considered. With 
all three of the studies, the sample size is small. Kluger et al. had the biggest sample size and it 
was only 94 participants.6 Another limitation in all three studies is differences in skill between 
those administering acupuncture in needle insertion. Placements may not have been as accurate 
between practitioners. Chen et al. was also limited in that the study was not randomized and not 
blinded.2 While the study states that other measures were taken to limit bias, without blinding, 
there are expectations and previous beliefs from the study workers and participants that may 
have influenced the results of the study. For Kluger et al., the study had excluded PD patients 
that did not have fatigue.6 For the purposes of their study, this was acceptable; however, for this 
current review, it limits the generalization of the results.  
Toosizadeh et al. also had limitations. It is not stated in the article whether all subjects 
were accounted for at the end of the study. Therefore, there could have been bias in data analysis 
Chon, acupuncture in PD    10 
 
if certain patient data was not included. There is a similar limitation in Kluger et al. where the 
intention to treat is conducted using the last observation carried forward.6 However, they do not 
specify if there was a certain number of patient data that were not included. Compared to the 
other two studies in this review, Toosizadeh et al. had a much shorter treatment period. Its 
participants received three treatment sessions, as opposed to Chen et al., who had 36 treatment 
sessions, and Kluger et al., who had 12 treatment sessions.2,5,6 Therefore, Toosizadeh et al. is 
limited in that they might not have provided enough treatments to reach efficacy.  
Conclusions 
 The evidence on whether acupuncture and electroacupuncture can improve quality of life 
in Parkinson’s disease patients is conflicting. Chen et al. and Toosizadeh both show significant 
improvements in activities of daily living, which indicate an improvement in quality of life, 
when receiving acupuncture or electroacupuncture, respectively.2,5 However, Chen et al. only 
showed a significant difference when comparing the experimental and control group, but no 
significant difference after acupuncture treatment from baseline.2 On the other hand, Kluger et al. 
showed no significant improvement in quality of life after acupuncture treatment when compared 
to the control group.6 However, it did show a significant improvement when the experimental 
group and control group were compared to each respective baseline.  
 For future studies, it would be interesting to see if acupuncture treatment is only effective 
at a certain stage of Parkinson’s disease. Subjective scores using the UPDRS II or PDQ39 would 
be taken before acupuncture treatment and subjects would be split into groups depending on the 
severity of their scores. Studies may show acupuncture to only provide a benefit at certain score 
severities. It would also be beneficial to study different lengths of treatment for acupuncture to 
Chon, acupuncture in PD    11 
 
see how long a person with Parkinson’s disease should attend acupuncture treatment for efficacy 
and also to see when the treatment becomes less effective.  
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